Terms: = Endocrine gland cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Treatment
25 results:
1. A prospective study comparing the gasless endoscopic thyroidectomy trans-axillary approach to conventional open thyroidectomy: health and quality of life outcomes.
Xu T; Qin X; Zhang Y; Li P; Ran Y; Fan Y; Zheng X; Wei T
Surg Endosc; 2024 Apr; 38(4):1995-2009. PubMed ID: 38396084
[TBL] [Abstract] [Full Text] [Related]
2. [Preliminary experience of gasless transoral vestibular robotic thyroidectomy].
Liang FY; Lin PL; Lin XJ; Han P; Chen RH; Wang JY; Zou X; Huang XM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Jun; 58(6):596-601. PubMed ID: 37339900
[No Abstract] [Full Text] [Related]
3. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
[TBL] [Abstract] [Full Text] [Related]
4. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract] [Full Text] [Related]
5. Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
Brum MCM; Dos Santos Guimaraes I; Ferreira LB; Rangel LBA; Maia RC; Nestal De Moraes G; Gimba ERP
Oncol Rep; 2021 Feb; 45(2):652-664. PubMed ID: 33416171
[TBL] [Abstract] [Full Text] [Related]
6. Roads to the strategic targeting of ovarian cancer treatment.
Irusta G
Reproduction; 2021 Jan; 161(1):R1-R11. PubMed ID: 33112290
[TBL] [Abstract] [Full Text] [Related]
7. Novel extra cellular-like matrices to improve human ovarian grafting.
Abir R; Stav D; Taieb Y; Gabbay-Benziv R; Kirshner M; Ben-Haroush A; Freud E; Ash S; Yaniv I; Herman-Edelstein M; Fisch B; Shufaro Y
J Assist Reprod Genet; 2020 Sep; 37(9):2105-2117. PubMed ID: 32710268
[TBL] [Abstract] [Full Text] [Related]
8. [Hepatic and Pancreatic Metastases of a Rectal Gastrointestinal Stromal Tumor in a Patient with Long-Term Survival following Combined Therapy-ACase Report].
Goto T; Sendo H; Yamazaki T; Ishida R; Yasuda T; Muramatsu S; Tsukamoto Y; Miyashita M; Ku Y
Gan To Kagaku Ryoho; 2019 Feb; 46(2):300-302. PubMed ID: 30914540
[TBL] [Abstract] [Full Text] [Related]
9. Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China.
Wang Y; Fan S; Wang H; Li L; Jia Y; Chai L
Support Care Cancer; 2018 Sep; 26(9):3267-3275. PubMed ID: 29644472
[TBL] [Abstract] [Full Text] [Related]
10. pdgfb as a vascular normalization agent in an ovarian cancer model treated with a gamma-secretase inhibitor.
Pazos MC; Sequeira G; Bocchicchio S; May M; Abramovich D; Parborell F; Tesone M; Irusta G
J Cell Physiol; 2018 Aug; 233(8):5949-5961. PubMed ID: 29266203
[TBL] [Abstract] [Full Text] [Related]
11. Effectiveness of Imatinib Mesylate treatment in a Patient with Dermatofibrosarcoma Protuberans with Pulmonary and Pancreatic Metastases.
Tatai T; Gomi D; Fukushima T; Kobayashi T; Sekiguchi N; Sakamoto A; Sasaki S; Koizumi T; Sano K
Intern Med; 2016; 55(17):2507-11. PubMed ID: 27580559
[TBL] [Abstract] [Full Text] [Related]
12. RET mutation and increased angiogenesis in medullary thyroid carcinomas.
Verrienti A; Tallini G; Colato C; Boichard A; Checquolo S; Pecce V; Sponziello M; Rosignolo F; de Biase D; Rhoden K; Casadei GP; Russo D; Visani M; Acquaviva G; Ferdeghini M; Filetti S; Durante C
Endocr Relat Cancer; 2016 Aug; 23(8):665-76. PubMed ID: 27402614
[TBL] [Abstract] [Full Text] [Related]
13. The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors.
Juliachs M; Muñoz C; Moutinho CA; Vidal A; Condom E; Esteller M; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
Clin Cancer Res; 2014 Feb; 20(3):658-67. PubMed ID: 24277456
[TBL] [Abstract] [Full Text] [Related]
14. Borderline tumors of the ovary: clinical course and prognostic factors.
Ewald-Riegler N; du Bois O; Fisseler-Eckhoff A; Kommoss F; Harter P; Traut A; Hils R; du Bois A
Onkologie; 2012; 35(1-2):28-33. PubMed ID: 22310342
[TBL] [Abstract] [Full Text] [Related]
15. Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.
Taeger J; Moser C; Hellerbrand C; Mycielska ME; Glockzin G; Schlitt HJ; Geissler EK; Stoeltzing O; Lang SA
Mol Cancer Ther; 2011 Nov; 10(11):2157-67. PubMed ID: 21885862
[TBL] [Abstract] [Full Text] [Related]
16. BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas.
Durante C; Tallini G; Puxeddu E; Sponziello M; Moretti S; Ligorio C; Cavaliere A; Rhoden KJ; Verrienti A; Maranghi M; Giacomelli L; Russo D; Filetti S
Eur J Endocrinol; 2011 Sep; 165(3):455-63. PubMed ID: 21653734
[TBL] [Abstract] [Full Text] [Related]
17. Expression of angiogenic factors in craniopharyngiomas: implications for tumor recurrence.
Sun HI; Akgun E; Bicer A; Ozkan A; Bozkurt SU; Kurtkaya O; Koc DY; Pamir MN; Kilic T
Neurosurgery; 2010 Apr; 66(4):744-50; discussion 750. PubMed ID: 20190664
[TBL] [Abstract] [Full Text] [Related]
18. Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.
Lu C; Shahzad MM; Moreno-Smith M; Lin YG; Jennings NB; Allen JK; Landen CN; Mangala LS; Armaiz-Pena GN; Schmandt R; Nick AM; Stone RL; Jaffe RB; Coleman RL; Sood AK
Cancer Biol Ther; 2010 Feb; 9(3):176-82. PubMed ID: 20009575
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
McCarty MF; Somcio RJ; Stoeltzing O; Wey J; Fan F; Liu W; Bucana C; Ellis LM
J Clin Invest; 2007 Aug; 117(8):2114-22. PubMed ID: 17641778
[TBL] [Abstract] [Full Text] [Related]
20. Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy.
Hoffmann S; Wunderlich A; Celik I; Maschuw K; Hassan I; Hofbauer LC; Zielke A
J Cell Biochem; 2006 Jul; 98(4):954-65. PubMed ID: 16475167
[TBL] [Abstract] [Full Text] [Related]
[Next]
